Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Põder · SciRah

Researcher profile · Semantic Scholar

A. Põder

Share profile

A. Põder — researcher profile on SciRah

h-index: 16
Works: 39
Citations: 2,511

Most-cited papers

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
A. Cunningham, R. Chlibek, J. Díez-Domingo, E. Athan +14 more
2015New England Journal of Medicine1,304 citations Open access
Semantic Scholar
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.
C. Pedersen, T. Petäjä, G. Strauss, H. Rúmke +7 more
2007Journal of Adolescent Health315 citations
Semantic Scholar
A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
M. Cutolo, G. Myerson, R. Fleischmann, F. Lioté +8 more
2016Journal of Rheumatology209 citations
Semantic Scholar
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination
A. Strezova, J. Díez-Domingo, Kamal Al Shawafi, J. Tinoco +173 more
2022Open Forum Infectious Diseases97 citations Open access
Semantic Scholar
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
C. Boutry, Andrew Hastie, J. Díez-Domingo, J. Tinoco +164 more
2021Clinical Infectious Diseases92 citations Open access
Semantic Scholar
Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women
T. Petäjä, C. Pedersen, A. Põder, G. Strauss +4 more
2011International Journal of Cancer92 citations Open access
Semantic Scholar
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
Marta López-Fauqued, L. Cámpora, Frédérique Delannois, M. El Idrissi +50 more
2019Vaccine60 citations Open access
Semantic Scholar
Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.
Himal Lal, A. Põder, L. Cámpora, B. Geeraerts +3 more
2018Vaccine50 citations Open access
Semantic Scholar
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial.
C. Maréchal, Himal Lal, A. Põder, Murdo Ferguson +7 more
2018Vaccine33 citations Open access
Semantic Scholar
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.
J. Beran, H. Reynales, A. Põder, Charles Y Yu +10 more
2021Lancet. Infectious Diseases (Print)31 citations
Semantic Scholar
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1).
F. Martinón-Torres, J. Wysocki, L. Szenborn, Alfonso Carmona-Martinez +15 more
2023Vaccine30 citations Open access
Semantic Scholar
Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.
D. Willer, L. Oostvogels, A. Cunningham, Pierre Gervais +52 more
2019Vaccine30 citations Open access
Semantic Scholar
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
Terry Nolan, Alexandre C Fortanier, B. Leav, A. Põder +7 more
2021New England Journal of Medicine22 citations Open access
Semantic Scholar
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study
Sílvia Narejos Pérez, J. M. Ramón Torrell, A. Põder, I. Leroux-Roels +18 more
2023Open Forum Infectious Diseases20 citations Open access
Semantic Scholar
An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age.
A. Põder, P. Šimurka, Ping Li, Sumita Roy-Ghanta +1 more
2014Vaccine18 citations Open access
Semantic Scholar
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial.
R. Abu-Elyazeed, T. Heineman, G. Dubin, M. Fourneau +23 more
2013Vaccine18 citations
Semantic Scholar
Laboratory Diagnosis of Sexually Transmitted Infections in Estonia in 2001–2002: Shortcomings With Impact on Diagnostic Quality and Surveillance
P. Naaber, A. Uusküla, Janika Naaber, A. Põder +4 more
2005Sexually Transmitted Diseases16 citations
Semantic Scholar
Sexually Transmitted Infections in Estonia
A. Põder, J. Bingham
1999International Journal of STD and AIDS16 citations
Semantic Scholar
Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age
A. Põder, Janine Oberije, Jay Meyer, Peter Heymer +5 more
2023Vaccines12 citations Open access
Semantic Scholar
MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial.
Luis Rivera, P. Chanthavanich, A. Põder, P. Suryakiran +2 more
2018Vaccine10 citations Open access
Semantic Scholar
European guideline on the organization of a consultation for sexually transmitted infections
D. Gamoudi, S. Flew, M. Cusini, S. Benardon +2 more
20197 citations
Semantic Scholar
HIV in Europe.
A. Põder, M. Haldre
2014Clinical Dermatology7 citations
Semantic Scholar
Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
I. Galgani, A. Põder, R. Jogi, V. Anttila +9 more
2023Human Vaccines & Immunotherapeutics5 citations Open access
Semantic Scholar
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults
J. Díez-Domingo, J. Tinoco, A. Põder, E. Dinleyici +22 more
2021Human Vaccines & Immunotherapeutics5 citations Open access
Semantic Scholar
THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials
A. Kavanaugh, D. Gladman, Christopher J. Edwards, A. Põder +6 more
20164 citations
Semantic Scholar
Immunogenicity and Safety of 2 Doses of an Investigational Herpes Zoster Subunit Vaccine Administered 2, 6 or 12 Months Apart in Adults 50 Years and Older: Results of a Phase III, Randomized, Open-Label, Multicenter Trial
A. Põder, B. Geeraerts, Himal Lal, L. Oostvogels +2 more
20164 citations Open access
Semantic Scholar
Efficacy, immunogenicity, and safety of a cell culture-derived quadrivalent influenza vaccine compared with a non-influenza vaccine in infants and children across five influenza seasons: a phase 3, multinational, observer-blind, randomised controlled trial.
A. Põder, A. Ong-Lim, D. M. Rivera-Medina, Khalequ Zaman +7 more
2026The Lancet Child & Adolescent Health3 citations
Semantic Scholar
Evaluation of ID-PaGIA syphilis antibody test.
P. Naaber, Ene Makoid, Anneli Aus, K. Lõivukene +1 more
2009Indian Journal of Dermatology, Venereology and Leprology3 citations Open access
Semantic Scholar
The growing and important collaboration between BASHH and IUSTI-Europe
Rajul Patel, J. Sherrard, D. Richardson, A. Põder
2018Sexually Transmitted Infections1 citations
Semantic Scholar
FRI0512 Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (156-week) improvements in basdai in psoriatic arthritis patients: pooled results from 3 phase iii, randomized, controlled trials
P. Mease, H. Marzo-Ortega, A. Põder, F. E. Van den Bosch +5 more
20171 citations Open access
Semantic Scholar
THU0420 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in BASDAI in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials
P. Mease, H. Marzo-Ortega, A. Põder, F. E. Van den Bosch +5 more
20161 citations
Semantic Scholar
194 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104 Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials
A. Kavanaugh, D. Gladman, C. Edwards, A. Põder +6 more
20161 citations
Semantic Scholar
Immunogenicity and safety of MF59-adjuvanted H5N1 pandemic influenza vaccine in healthy infants and children: a phase 2 randomized, observer-blind, multicenter study.
A. Põder, M. Trinidad-Aseron, E. van Twuijver, Eve Versage +1 more
2026Vaccine0 citations Open access
Semantic Scholar
Corrigendum to "A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)" [Vaccine 41 (2023) 3387-3398].
F. Martinón-Torres, J. Wysocki, L. Szenborn, Alfonso Carmona-Martinez +15 more
2025Vaccine0 citations
Semantic Scholar
Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial' [Vaccine 36 (2018) 4278-4286].
C. Maréchal, Himal Lal, A. Põder, Murdo Ferguson +7 more
2019Vaccine0 citations Open access
Semantic Scholar
165 Apremilast, an oral phosphodiesterase-4 inhibitor, is associated with long-term (156-week) improvements in Bath Ankylosing Spondylitis Disease Activity Index Score in subjects with psoriatic arthritis: pooled results from three phase III randomised controlled trials
P. Mease, H. Marzo-Ortega, A. Põder, F. E. Van den Bosch +4 more
20180 citations
Semantic Scholar
P141 A service evaluation for and on behalf of the European Clinical Collaborative Group (ECCG) - The management of Gonorrhoea across Europe
H. Aadan, J. Mawdsley, Harriet Eatwell, E. Clarke +8 more
20160 citations Open access
Semantic Scholar
The challenges of controlling STIs across a diverse continent
A. Põder
20140 citations
Semantic Scholar
Molekulaarse kompleksdiagnostika olulisus suguteede infektsioonide diagnoosimisel
Paul Naaber, Kaspar Ratnik, Kristi Raud, E. Sepp +1 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Heineman×7
Invite
T. Heineman — researcher profile on SciRah
J. Díez-Domingo×6
Invite
J. Díez-Domingo — researcher profile on SciRah
Himal Lal×6
Invite
Himal Lal — researcher profile on SciRah
L. Oostvogels×6
Invite
L. Oostvogels — researcher profile on SciRah

×5

Invite

A. Cunningham — researcher profile on SciRah

J. Barba-Gómez×5

Invite

J. Barba-Gómez — researcher profile on SciRah

Invite

T. Zahaf — researcher profile on SciRah

Invite

L. Teng — researcher profile on SciRah

Invite

E. Athan — researcher profile on SciRah

Shinn-Jang Hwang×4

Invite

Shinn-Jang Hwang — researcher profile on SciRah

F. E. Van den Bosch×4

Invite

F. E. Van den Bosch — researcher profile on SciRah

H. Marzo-Ortega×4

Invite

H. Marzo-Ortega — researcher profile on SciRah